Showing results (641-650 of 1,523) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|January 24, 2025
Pharmacokinetics-Based Design of Subcutaneous Controlled Release Systems for BiologicsAbigail K Grosskopf, Antonio A Ginart, Phillip Spinosa, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 18, 2025
Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and MortalityHanna Kunina, Stefan Franzén, Maria C Kjellsson
CPT: Pharmacometrics & Systems Pharmacology|March 4, 2025
Evaluation of Adefovir PBPK Model to Assess Biomarker-Informed OAT1 Drug-Drug Interaction and Effect of Chronic Kidney DiseaseShawn Pei Feng Tan, Huaying Wu, Amin Rostami-Hodjegan, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 10, 2024
Semi-mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and AzacitidineNeha Thakre, Corinna Maier, Jiuhong Zha, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 10, 2024
A minimal physiologically-based pharmacokinetic modeling platform to predict intratumor exposure and receptor occupancy of an anti-LAG-3 monoclonal antibodyRobin Michelet, Klas Petersson, Marc C Huisman, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 2, 2024
Understanding the mechanisms of food effect on omaveloxolone pharmacokinetics through physiologically based biopharmaceutics modelingXavier J H Pepin, Scott M Hynes, Hamim Zahir, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 27, 2024
A fully automatic tool for development of population pharmacokinetic modelsXiaomei Chen, Rikard Nordgren, Stella Belin, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 23, 2024
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end pointsXiaomei Chen, Henrik B Nyberg, Mark Donnelly, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 29, 2024
Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methodsHenrik Bjugård Nyberg, Xiaomei Chen, Mark Donnelly, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 4, 2024
Population pharmacokinetic modeling of zavegepant, a calcitonin gene-related peptide receptor antagonist, in healthy adults and patients with migraineCraig M Comisar, Jose Francis, Jim H Hughes, et al.
Pageof 153